David Parkinson is a Scientific Advisor at Notable Labs. David has previously worked as a Venture Partner at New Enterprise Associates, Director of the Board of Directors at Tocagen, President and Chief Executive Officer at Nodality Inc., Senior Vice President at Biogen Idec, and Vice President of Oncology Research and Development and Clinical Development at Novartis.
David has over 20 years of experience in the biotechnology industry. David has a proven track record in developing and commercializing new drugs and diagnostics, leading successful companies, and creating shareholder value. David is an expert in oncology drug development and has played a critical role in the development of several novel cancer therapies that are now approved and marketed globally.
David holds a Bachelor of Science degree in Microbiology from the University of British Columbia and a Doctor of Philosophy in Molecular Biology from McMaster University.
Dr. David Parkinson is a medical doctor who graduated from the University of Toronto. David is currently a practicing physician.